Efficacy and safety of daratumumab plus bortezomib and dexamethasone in newly diagnosed Mayo 2004 stage IIIA or IIIB light-chain amyloidosis: a prospective phase II study
Kaini Shen, Yajuan Gao, Long Chang, Lu Zhang, Xinxin Cao, Zhuang Tian, Yining Wang, Daobin Zhou, Jian Li
Abstract
Not available.
Topics & Concepts
DaratumumabBortezomibAL amyloidosisMedicineDexamethasoneAmyloidosisStage (stratigraphy)Internal medicineMultiple myelomaOncologyImmunoglobulin light chainSurgeryImmunologyAntibodyBiologyPaleontologyAmyloidosis: Diagnosis, Treatment, OutcomesChronic Lymphocytic Leukemia ResearchNeuroendocrine Tumor Research Advances